In fact, although some inconsistencies across different studies emerged, it has been demonstrated that certain anti-migraine treatments may cause alteration in the level of sex hormones and prolactin (16), which in turn has been suggested to induce BC cell proliferation and spread and to be associated with increased BC risk (17–20). Here, PRL is linked to migraine disorder.